Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Qatar.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Zympass®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • Depakine®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Zympass®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • Depakine®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Science
    • Diabetes

    Diabetes

    Get a global overview and learn all about the changing world of Diabetes.

    Contact Medical Science Liaison

    Science in Diabetes

    Get a 360º view and stay updated on Diabetes with content selected for you

    The BRIGHT Study

    Basal insulin and beyond

    The Lixilan-L Study

    Covid-19 & Diabetes Treatment Guideline

    Hospitalization Rates for Acute Diabetes Complications

    Glycemic control in elderly people with T2D

    Prevalence of Diabetes in Children and Adolescents

    Reducing Risk of severe hypoglycemia: iNPHORM Study

    Unmet needs in adults with T2D receiving premixed insulin

    Insulin treatment intensification with GLP-1RA vs basal-plusbasal-bolus regimens

    New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

    Exploring the risk for severe hypoglycemia in the pool of studied patients with T1D

    SEE EVERYTHING

    Inspiration and innovation

    Get inspired and stay at the forefront of innovation with the following resources

    ADA 2021: Solimix Trial Summary

    5:12

    SoliMix Study Results Summary Video

    What is time-in-range?

    Impact of Time-in-Range

    5:23

    T1D Treatment Practice and the SAGE Study

    T1DM Mini-Series: Edition JUNIOR trial results

    02:45

    Diabetes Your Type: Testimonial by Dr. Hussein​

    02:20

    Diabetes Your Type: Testimonial by Dr. Bassam​

    04:57

    Diabetes Your Type: Testimonial by Dr. Nadia

    The value of time-in-range

    T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

    T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control

    SEE EVERYTHING

    Events

    Stay up to date and register for the latest events and view webinar recordings.

    100 Years of Insulin

    Diabetes Guidelines in Ramadan

    17:39

    Soliqua and Unmet Needs Webinar Summary

    Nutrition and Insulin management in Ramadan

    SEE EVERYTHING
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE |

    Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information:

    please contact: +971 565776791 or Email: medical-information.gulf@sanofi.com

    To report an adverse event:

    please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact: Email: quality.greatergulf@sanofi.com

     

    MAT-QA-2100056/V2/Nov 2021

    • Legal notice
    • Cookie policy
    • Privacy Policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the Qatar.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.